Stories > FDA Warns of Counterfeit Ozempic

FDA Warns of Counterfeit Ozempic

Anti-Obesity Meds' Impact on Allurion Pr...

Biden's $35 Insulin Price Cap

Biopharma Innovations in Obesity and Mus...

Novo Nordisk's Legal Action Against Phar...

Novo's Weight-Loss Pill Launch Challenge...